This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 30 MG TABLET, a medication, with a ceiling value of $15,393.16 and a completion date of July 8, 2025. The contract is firm fixed price and is not set aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 30 MG TABLET UU 30S, a pharmaceutical product. The contract has a ceiling value of $32,794.15 and a completion date of June 13, 2025. It is a firm fixed-price contract and is not set aside for any specific business type. AmerisourceBergen holds a significant...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, with a firm fixed price ceiling value of $19,418.72 and a completion date of July 1, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET, a pharmaceutical product, with a ceiling value of $5,041.29 and a completion date of December 28, 2022. The contract is a firm-fixed-price, non-set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $6,223.32 firm fixed-price contract provides RINVOQ ER 15 MG TABLET UU 30S, a specialty pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of December 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,071.05, is for the delivery of the drug RINVOQ ER 15 MG TABLET UU 30S. It is a firm fixed-price contract with a completion date of May 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 30 MG TABLET, a pharmaceutical product. The contract has a ceiling value of $10,780.17 and a completion date of May 1, 2025. It is a firm fixed-price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $48,659.85 and a period of performance through July 2, 2025. The contract is a firm fixed-price type and is not set aside for any particular business category. Amerisourcebergen Drug Corp holds a...
This is a Delivery Order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of RINVOQ ER 15 MG TABLET, a medication, with a ceiling value of $11,886.85 and a completion date of June 13, 2025. The contract is a Firm Fixed Price arrangement without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product, with a ceiling value of $36,952.26 and a completion date of May 20, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...